ArticleCancers2019

A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis.

Ya-Ting Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.